Wang, Y.-H.; Lai, C.-C.; Wang, C.-Y.; Wang, H.-C.; Yu, C.-J.; Chen, L.; On Behalf of the Taiwan Clinical Trial Consortium for Respiratory Diseases.
Risks of Pneumonia in COPD Patients with New-Onset Atrial Fibrillation. J. Clin. Med. 2018, 7, 229.
https://doi.org/10.3390/jcm7090229
AMA Style
Wang Y-H, Lai C-C, Wang C-Y, Wang H-C, Yu C-J, Chen L, On Behalf of the Taiwan Clinical Trial Consortium for Respiratory Diseases.
Risks of Pneumonia in COPD Patients with New-Onset Atrial Fibrillation. Journal of Clinical Medicine. 2018; 7(9):229.
https://doi.org/10.3390/jcm7090229
Chicago/Turabian Style
Wang, Ya-Hui, Chih-Cheng Lai, Cheng-Yi Wang, Hao-Chien Wang, Chong-Jen Yu, Likwang Chen, and On Behalf of the Taiwan Clinical Trial Consortium for Respiratory Diseases.
2018. "Risks of Pneumonia in COPD Patients with New-Onset Atrial Fibrillation" Journal of Clinical Medicine 7, no. 9: 229.
https://doi.org/10.3390/jcm7090229
APA Style
Wang, Y.-H., Lai, C.-C., Wang, C.-Y., Wang, H.-C., Yu, C.-J., Chen, L., & On Behalf of the Taiwan Clinical Trial Consortium for Respiratory Diseases.
(2018). Risks of Pneumonia in COPD Patients with New-Onset Atrial Fibrillation. Journal of Clinical Medicine, 7(9), 229.
https://doi.org/10.3390/jcm7090229